Qin Wang

Qin Wang

Auto-generated profile, based on publicly available information

Qin Wang

Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, 610031, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
QWQin Wang
Qin Wang
XQXianyan Qin
Xianyan Qin
JFJiyu Fang
Jiyu Fang
XSXun Sun
Xun Sun
Increasing understanding of the pathogenesis of rheumatoid arthritis (RA) has remarkably promoted the development of effective therapeutic regimens of RA. Nevertheless, the inadequate response to current therapies in a proportion of patients, the systemic toxicity accompanied by long-term administration or distribution in non-targeted sites and the comprised efficacy caused by undesirable bioavailability, are still unsettled problems lying across the full remission of RA. So far, these existing limitations have inspired comprehensive academic researches on nanomedicines for RA treatment. A variety of versatile nanocarriers with controllable physicochemical properties, tailorable drug release pattern or active targeting ability were fabricated to enhance the drug delivery efficiency in RA treatment. This review aims to provide an up-to-date progress regarding to RA treatment using nanomedicines in the last 5 years and concisely discuss the potential application of several newly emerged therapeutic strategies such as inducing the antigen-specific tolerance, pro-resolving therapy or regulating the immunometabolism for RA treatments.

29 April 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
LHLiming He
Liming He
XQXianyan Qin
Xianyan Qin
DFDonghao Fan
Donghao Fan
CFChenglan Feng
Chenglan Feng
QWQin Wang
Qin Wang
JFJiyu Fang
Jiyu Fang

15 January 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
QWQin Wang
Qin Wang
LHLiming He
Liming He
DFDonghao Fan
Donghao Fan
WLWenlang Liang
Wenlang Liang
JFJiyu Fang
Jiyu Fang
Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints of the body. Although liposomes are a promising drug delivery vehicle, there is still a challenge of using conventional liposomes for the treatment of RA due to their short circulation time and physicochemical instability in blood vessels. Here, we report the formation of polymerized stealth liposomes composed of 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine (DC8,9PC) and 1,2-distearoyl-sn-glycero-3-phospho-ethanolamine-poly(ethyleneglycol) (DSPE-PEG2000) with a thin-film hydration method, in which DC8,9PC molecules are cross-linked in the bilayer of the liposomes by UV irradiation and the PEG chains present at the surface of the liposomes provide a stealth layer. We demonstrate that the polymerized stealth liposomes are stable and show long circulation time in blood vessels. They can be internalized by cells without significant toxicity. After being injected into arthritic rats, the polymerized stealth liposomes with loaded dexamethasone (Dex) show long blood circulation time and accumulate preferentially in inflamed joints, consequently suppressing the level of proinflammatory cytokines (TNF-α and IL-1β) in joint tissues, reducing the swelling of inflamed joints and alleviating the progression of RA. We believe that polymerized stealth liposomes can be used as a promising drug delivery vehicle for various therapeutic applications.

9 November 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
XQXianyan Qin
Xianyan Qin
LPLihua Pan
Lihua Pan
TCTao Chen
Tao Chen
DLDaming Li
Daming Li
XLXin Lin
Xin Lin
QWQin Wang
Qin Wang

2 August 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
DLDaming Li
Daming Li
JLJiao Li
Jiao Li
TCTao Chen
Tao Chen
XQXianyan Qin
Xianyan Qin
LPLihua Pan
Lihua Pan
QWQin Wang
Qin Wang

16 August 2024 in Biomaterials
Verified
Journal Article
Closed access
QWQin Wang
Qin Wang
JRJianheng Ren
Jianheng Ren
XLXin Lin
Xin Lin
BZBin Zhang
Bin Zhang
JLJiao Li
Jiao Li
YWYajun Weng
Yajun Weng